AC
KRSA

AWH Capital’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

AWH Capital’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-374
Closed -$310K – 47
2020
Q2 		$310K Sell
374
-1,947
-84% -$163K 0.61% 28
2020
Q1 		$861K Sell
2,321
-1,893
-45% -$135K 4.66% 7
2019
Q4 		$1.6M Buy
4,214
+4,050
+2,470% +$378K 1.87% 17
2019
Q3 		$278K Buy
164
+92
+128% +$19.9K 0.35% 24
2019
Q2 		$116K Buy
+72
New +$20.4K 0.17% 23

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AWH Capital's KRSA Position: Q3 2020 in Review

AWH Capital sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2020, closing a stake of 374 shares — an estimated $310K sold.

AWH Capital first reported a position in KRSA in Q2 2019 and held it in 5 quarters. The position peaked at $1.6M in Q4 2019. 69 funds tracked by Wall St. Rank hold KRSA as of Q3 2020.

  • AWH Capital reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • AWH Capital sold 374 Korsana Biosciences, Inc. Common Stock shares in Q3 2020, an estimated $310K.
  • AWH Capital first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 5 quarters.
  • AWH Capital's Korsana Biosciences, Inc. Common Stock position peaked at $1.6M in Q4 2019.
  • 69 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2020.

Based on AWH Capital's 13F filing for Q3 2020, filed 16 Nov 2020.